BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 9665467)

  • 1. Pattern of graft- and host-specific MHC class II expression in long-term murine cardiac allografts: origin of inflammatory and vascular wall cells.
    Hasegawa S; Becker G; Nagano H; Libby P; Mitchell RN
    Am J Pathol; 1998 Jul; 153(1):69-79. PubMed ID: 9665467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of MHC and non-MHC genes on the nature of murine cardiac allograft rejection. I. Kinetic analysis of mononuclear cell infiltrate and MHC-class I/class II expression in donor tissue.
    Wang YC; Mayne A; Sell KW; Ahmed-Ansari A
    Transplantation; 1990 Aug; 50(2):313-24. PubMed ID: 2200176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary arteriosclerosis after T-cell-mediated injury in transplanted mouse hearts: role of interferon-gamma.
    Nagano H; Libby P; Taylor MK; Hasegawa S; Stinn JL; Becker G; Tilney NL; Mitchell RN
    Am J Pathol; 1998 May; 152(5):1187-97. PubMed ID: 9588888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
    Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM
    J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered intragraft immune responses and improved renal function in MHC class II-deficient mouse kidney allografts.
    Mannon RB; Doyle C; Griffiths R; Bustos M; Platt JL; Coffman TM
    Transplantation; 2000 May; 69(10):2137-43. PubMed ID: 10852613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4+ T cells.
    Kapessidou Y; Habran C; Buonocore S; Flamand V; Barvais L; Goldman M; Braun MY
    Transplantation; 2006 Aug; 82(4):582-91. PubMed ID: 16958183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4 T cell-mediated cardiac allograft rejection requires donor but not host MHC class II.
    Pietra BA; Wiseman A; Bolwerk A; Rizeq M; Gill RG
    J Clin Invest; 2000 Oct; 106(8):1003-10. PubMed ID: 11032860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4(+) T cells.
    Kapessidou Y; Habran C; Buonocore S; Flamand V; Barvais L; Goldman M; Braun MY
    Transplantation; 2006 Mar; 81(5):726-35. PubMed ID: 16534475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptides derived from alpha-helices of allogeneic class I major histocompatibility complex antigens are potent inducers of CD4+ and CD8+ T cell and B cell responses after cardiac allograft rejection.
    Shirwan H; Leamer M; Wang HK; Makowka L; Cramer DV
    Transplantation; 1995 Feb; 59(3):401-10. PubMed ID: 7871571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular cell adhesion molecule-1 is induced on vascular endothelia and medial smooth muscle cells in experimental cardiac allograft vasculopathy.
    Ardehali A; Laks H; Drinkwater DC; Ziv E; Drake TA
    Circulation; 1995 Aug; 92(3):450-6. PubMed ID: 7543379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged allograft survival in anti-CD4 antibody transgenic mice: lack of residual helper T cells compared with other CD4-deficient mice.
    Han WR; Zhan Y; Murray-Segal LJ; Brady JL; Lew AM; Mottram PL
    Transplantation; 2000 Jul; 70(1):168-74. PubMed ID: 10919596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary atherosclerosis in transplanted mouse hearts. I. Time course and immunogenetic and immunopathological considerations.
    Russell PS; Chase CM; Winn HJ; Colvin RB
    Am J Pathol; 1994 Feb; 144(2):260-74. PubMed ID: 7906094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Graft-specific MHC class II gene expression in response to allogeneic stimulus in heterotopic murine cardiac allografts.
    Xu R; Burdick JF; Scott A; Beschorner WE; Adler W; Kittur DS
    Immunology; 1992 Feb; 75(2):361-5. PubMed ID: 1551698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of myeloid related protein-8/14 exacerbates cardiac allograft rejection.
    Shimizu K; Libby P; Rocha VZ; Folco EJ; Shubiki R; Grabie N; Jang S; Lichtman AH; Shimizu A; Hogg N; Simon DI; Mitchell RN; Croce K
    Circulation; 2011 Dec; 124(25):2920-32. PubMed ID: 22144572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of peripheral tolerance in anti-CD4 treated C57BL/6 mouse heart transplants recipients.
    Han WR; Murray-Segal LJ; Mottram PL
    Transpl Immunol; 1999 Mar; 7(1):37-44. PubMed ID: 10375076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging the rejecting heart. In vivo detection of major histocompatibility complex class II antigen induction.
    Isobe M; Narula J; Southern JF; Strauss HW; Khaw BA; Haber E
    Circulation; 1992 Feb; 85(2):738-46. PubMed ID: 1735166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell and major histocompatibility complex requirements for obliterative airway disease in heterotopically transplanted murine tracheas.
    Kelly KE; Hertz MI; Mueller DL
    Transplantation; 1998 Sep; 66(6):764-71. PubMed ID: 9771840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Passive transfer of alloantibodies restores acute cardiac rejection in IgKO mice.
    Wasowska BA; Qian Z; Cangello DL; Behrens E; Van Tran K; Layton J; Sanfilippo F; Baldwin WM
    Transplantation; 2001 Mar; 71(6):727-36. PubMed ID: 11330533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of PECAM-1 in acute rejection of fully major histocompatibility complex class II-mismatched cardiac allografts in mice.
    Schramm R; Menger MD; Schmits R; Harder Y; Kirsch S; Meier C; Schäfers HJ
    Transplantation; 2007 Aug; 84(4):555-8. PubMed ID: 17713444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of donor MHC class I or class II antigen deficiency on first- and second-set rejection of mouse heart or liver allografts.
    Qian S; Fu F; Li Y; Lu L; Rao AS; Starzl TE; Thomson AW; Fung JJ
    Immunology; 1996 May; 88(1):124-9. PubMed ID: 8707337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.